↪ The Smartest Pill You’ll Ever Swallow↩

•Own 80% of a Leading Philippine Pharma Wholesaler
•Asset-Backed • Debt-Free • Expansion-Ready

•Purchase up to 80% equity for USD 54.5M
➨USD 167M Independent Valuation
➨Zero Debt at Close

Deal Snapshot – What You’re Getting:
Metric Value (USD)
Enterprise Value 166.6M
Business Valuation 127.5M
Real Estate (Clean-Titled) 42.8M
80% Equity Stake 133.3M
Your Offer Price (80%) 54.5M
Immediate Discount >59% vs Valuation
Real Estate Security 42.8M
Debt at Close Zero

• You're acquiring a USD 133M stake in a debt-free, asset-backed enterprise for just USD 54.5M — a rare blend of downside protection and upside potential.

Why This Is Strategic?

✔25-year operating history


✔24,500+ active clients incl. Mercury Drug, DOH, LGUs, hospitals


✔ 40+ domestic & global suppliers


✔ Government & institutional contracts


✔ Retail & wholesale expansion already funded


✔ All liabilities extinguished at close — buyer inherits a clean-cap, zero-debt company


✔ 2-year transition & consultancy agreement with retiring founders

Market Tailwinds: Durable Growth, Defensive Sector

➨ PH over-the-counter pharma market forecast at USD 12.6B by 2030 (9% CAGR)


➨SEA healthcare distribution market to grow from USD 18B to USD 26B by 2029 (7% CAGR)


➨This deal: very few comparables offer USD 42.8M in hard assets

💊 The Smartest Pill You’ll Ever Swallow

Own 80% of a Leading Philippine Pharma Wholesaler • Asset-Backed • Debt-Free • Expansion-Ready

Purchase up to 80% equity for USD 54.5M
USD 167M independent valuation — Zero debt at close
Metric Value (USD)
Enterprise Value 166.6M
Business Valuation 127.5M
Real Estate (Clean-Titled) 42.8M
80% Equity Stake 133.3M
Your Offer Price (80%) 54.5M

Why this is strategic

  • 25-year operating history
  • 24,500+ active clients incl. Mercury Drug, DOH, LGUs, hospitals
  • 40+ domestic & global suppliers; government & institutional contracts
  • Retail & wholesale expansion already funded; liabilities extinguished at close
  • 2-year transition & consultancy agreement with retiring founders

Market tailwinds

PH OTC market forecast: USD 12.6B by 2030 (9% CAGR). SEA distribution market: USD 18B → USD 26B by 2029 (7% CAGR).

Next step — Secure Data Room Access

Click below to review our confidentiality terms and complete your request for access. Once approved, you’ll receive full data room access.

Book Private Investor Briefing & Request Access

You can review the NDA here before signing: View NDA (PDF)

After NDA approval, you will receive access to:

  • Investor Memorandum
  • Financial Statements
  • Valuation Reports
  • Franchise Rollout Plan
  • Legal & Compliance Summary

Lead & Exclusive Broker

Joey Lapena (PH)
📞 +63 916 639 4807
✉ joey@armadagroups.com | jplapena@yahoo.com

Rocco Pennisi (AU)
📞 +61 418 745 398
✉ success@armadagroups.com

Disclaimer: All USD figures converted at PHP 56.6:1. Terms subject to definitive agreements and due diligence. Offer closes once fully subscribed.

Next step: Book a private investor briefing with Armada Group

click to sign sign up for data room access

Joey Lapena (PH)
 📞 +63 916 639 4807


📧 joey@armadagroups.com | jplapena@yahoo.com

Rocco Pennisi (AU)
📞 +61 418 745 398


📧 success@armadagroups.com
🌐 www.armadagroups.com

Disclaimer:All USD figures converted at PHP 56.6:1.
Terms subject to definitive agreements and due diligence.
Offer closes once fully subscribed.